• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-term outcome of adult-onset minimal-change nephropathy.

作者信息

Mak S K, Short C D, Mallick N P

机构信息

Department of Renal Medicine, Manchester Royal Infirmary, UK.

出版信息

Nephrol Dial Transplant. 1996 Nov;11(11):2192-201. doi: 10.1093/oxfordjournals.ndt.a027136.

DOI:10.1093/oxfordjournals.ndt.a027136
PMID:8941578
Abstract

BACKGROUND

Adult-onset minimal-change nephropathy has been associated with a slower response to corticosteroids and a less benign prognosis when compared to children. However, there are few long-term outcome data reported.

METHODS

We have reviewed retrospectively 51 idiopathic adult-onset minimal-change nephropathy patients investigated and treated at a single centre.

RESULTS

Male to female ratio was 1:1.4, mean age at diagnosis was 37 years, and average length of follow-up was 14.1 years. Significant comorbidity was identified in 33%. A raised serum creatinine was found in 55% but returned to normal almost invariably upon remission. At presentation, hypertension was found in 47% of patients, microscopic haematuria in 33%, hypercholesterolaemia and hypertriglyceridaemia in 96%, and hyperuricaemia in 42%. Remission (complete or partial) was achieved by 46, 70 and 92% within 4, 8 and 21 weeks respectively, in patients treated with steroids; steroid resistance was encountered in 8%. The time to remission was positively correlated with age (P = 0.002) and initial albumin level (P = 0.005), and negatively correlated to the number of subsequent relapses (P = 0.029); 33% of patients had a spontaneous remission at some time during the disease course. Patients with multiple relapses were treated with cyclophosphamide and 63% of them had remained in remission after 5 years. Hypertension was present in 25% of patients after an average interval of 11 years. At the time of the final follow-up, only three patients had a raised creatinine and all but three patients were in complete remission.

CONCLUSIONS

Adult-onset minimal-change nephropathy shares the same good long-term outcome as the childhood counterpart, with sustained remission and preserved renal function.

摘要

相似文献

1
Long-term outcome of adult-onset minimal-change nephropathy.
Nephrol Dial Transplant. 1996 Nov;11(11):2192-201. doi: 10.1093/oxfordjournals.ndt.a027136.
2
The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.成人或青少年晚期起病的微小病变肾病综合征的临床病程:病例系列。
Am J Kidney Dis. 2017 May;69(5):637-646. doi: 10.1053/j.ajkd.2016.10.032. Epub 2017 Jan 12.
3
Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.他克莫司治疗对类固醇和环磷酰胺耐药的成人肾病综合征且肾小球滤过率正常或轻度降低者。
Am J Kidney Dis. 2009 Jul;54(1):51-8. doi: 10.1053/j.ajkd.2009.02.018. Epub 2009 May 5.
4
Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.中国人活检证实的微小病变肾病的长期预后。
Am J Kidney Dis. 2015 May;65(5):710-8. doi: 10.1053/j.ajkd.2014.09.022. Epub 2014 Oct 30.
5
Minimal-change glomerulopathy of adulthood.成人微小病变性肾小球病
Am J Nephrol. 1988;8(4):291-7. doi: 10.1159/000167603.
6
Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.成人起病型微小病变肾病综合征的类固醇反应性及复发频率
Am J Kidney Dis. 2002 Mar;39(3):503-12. doi: 10.1053/ajkd.2002.31400.
7
Adult minimal-change disease: clinical characteristics, treatment, and outcomes.成人微小病变病:临床特征、治疗及预后
Clin J Am Soc Nephrol. 2007 May;2(3):445-53. doi: 10.2215/CJN.03531006. Epub 2007 Apr 11.
8
Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.IgA肾病合并微小病变病患者与微小病变病患者之间的比较。
Clin Nephrol. 2016 May;85(5):273-81. doi: 10.5414/CN108727.
9
Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.老年特发性微小病变肾病综合征:类固醇反应性及复发模式
Nephrol Dial Transplant. 2003 Jul;18(7):1316-20. doi: 10.1093/ndt/gfg134.
10
Adult-onset minimal change nephrotic syndrome: a long-term follow-up.成人起病的微小病变肾病综合征:长期随访
Kidney Int. 1986 Jun;29(6):1215-23. doi: 10.1038/ki.1986.130.

引用本文的文献

1
Adult minimal change disease: Clinicopathologic characteristics, treatment response and outcome at a single center in Pakistan.成人微小病变病:巴基斯坦某单一中心的临床病理特征、治疗反应及预后
World J Nephrol. 2024 Dec 25;13(4):99643. doi: 10.5527/wjn.v13.i4.99643.
2
Diagnostic Challenges in Nephrotic Syndrome Presenting With Venous Thromboembolism.肾病综合征合并静脉血栓栓塞的诊断挑战
Cureus. 2024 Oct 9;16(10):e71173. doi: 10.7759/cureus.71173. eCollection 2024 Oct.
3
Relationship between time to clinical remission and relapse in adults with steroid-sensitive minimal change disease: a retrospective cohort study.
成人激素敏感型微小病变性肾病临床缓解至复发时间的关系:一项回顾性队列研究。
Ann Med. 2024 Dec;56(1):2409344. doi: 10.1080/07853890.2024.2409344. Epub 2024 Oct 10.
4
Activation of the inflammasome and pyroptosis cascade in podocytes of patients with minimal change disease.微小病变病患者足细胞中炎性小体的激活及细胞焦亡级联反应。
Clin Kidney J. 2024 Jul 16;17(8):sfae216. doi: 10.1093/ckj/sfae216. eCollection 2024 Aug.
5
Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis.成人类固醇依赖型或频繁复发型肾病综合征的免疫抑制治疗:系统评价和荟萃分析。
PLoS One. 2024 Jul 31;19(7):e0307981. doi: 10.1371/journal.pone.0307981. eCollection 2024.
6
Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group.成人足细胞病的治疗:欧洲肾脏学会免疫肾脏病学工作组的最新进展。
Nephrol Dial Transplant. 2024 Mar 27;39(4):569-580. doi: 10.1093/ndt/gfae025.
7
[Diagnosis and treatment of Minimal Change Disease in adults-2023].[成人微小病变病的诊断与治疗 - 2023]
Wien Klin Wochenschr. 2023 Aug;135(Suppl 5):628-637. doi: 10.1007/s00508-023-02258-5. Epub 2023 Sep 20.
8
Outcomes of minimal change disease without nephrotic range proteinuria.无微小球性肾炎肾病范围蛋白尿的结局。
PLoS One. 2023 Aug 17;18(8):e0289870. doi: 10.1371/journal.pone.0289870. eCollection 2023.
9
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse.低剂量利妥昔单抗治疗微小病变性肾病及预防复发的疗效。
BMC Nephrol. 2023 Apr 26;24(1):112. doi: 10.1186/s12882-023-03092-7.
10
Steroid Minimization in Adults with Minimal Change Disease.微小病变型肾病成人患者的激素减量治疗
Glomerular Dis. 2021 Jul 29;1(4):237-249. doi: 10.1159/000517626. eCollection 2021 Oct.